Prospective, multicenter, single arm, post-market study to evaluate real world clinical outcomes in ESRD patients receiving in-home dialysis on the Tablo Hemodialysis System.
Study Type
OBSERVATIONAL
Enrollment
500
Home hemodialysis treatments \~4 times a week.
Satellite Healthcare, Inc.
San Jose, California, United States
RECRUITINGDesert Cities Dialysis
Victorville, California, United States
COMPLETEDBerkshire Medical Center
Weekly Standardized Dialysis Adequacy
Weekly standardized dialysis adequacy (stdKt/V) measured using the second-generation formula of Daugirdas. This formula normalizes urea clearance among heterogeneous hemodialysis schedules, where K=dialyzer clearance or urea, t=treatment time, and V=subject's volume of urea distribution. stdKt/V values of ≥ 2.1 are regarded as being adequate.
Time frame: 12-months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Pittsfield, Massachusetts, United States
St. Peter's Health
Helena, Montana, United States
RECRUITINGDialysis Center of Lincoln
Lincoln, Nebraska, United States
RECRUITINGParker Jewish Institute
New Hyde Park, New York, United States
RECRUITINGNYU Grossman School of Medicine
New York, New York, United States
RECRUITINGRogosin Institute
New York, New York, United States
RECRUITINGUSRC Kidney Research
Plano, Texas, United States
RECRUITINGUniversity of Virginia
Staunton, Virginia, United States
WITHDRAWN